Giovanna Rege-Cambrin

Giovanna Rege-Cambrin

UNVERIFIED PROFILE

Are you Giovanna Rege-Cambrin?   Register this Author

Register author
Giovanna Rege-Cambrin

Giovanna Rege-Cambrin

Publications by authors named "Giovanna Rege-Cambrin"

Are you Giovanna Rege-Cambrin?   Register this Author

55Publications

1479Reads

33Profile Views

Philadelphia-positive lymphoblastic lymphoma: a case report and review of the literature.

Stem Cell Investig 2019 9;6:17. Epub 2019 Jul 9.

Azienda Ospedaliero Universitaria San Luigi Gonzaga, Università di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/sci.2019.06.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691076PMC
July 2019

Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor.

Clin Lymphoma Myeloma Leuk 2016 08 1;16 Suppl:S96-S100. Epub 2016 Apr 1.

Department of Clinical and Biological Sciences, University of Turin, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano (TO), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.03.008DOI Listing
August 2016

Update on emerging treatments for chronic myeloid leukemia.

Expert Opin Emerg Drugs 2015 Jun 31;20(2):183-96. Epub 2015 Mar 31.

University of Turin, San Luigi Hospital, Department of Clinical and Biological Sciences , Orbassano 10043 , Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2015.1031217DOI Listing
June 2015

The choice of first-line chronic myelogenous leukemia treatment.

Ann Hematol 2015 Apr 27;94 Suppl 2:S123-31. Epub 2015 Mar 27.

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, "San Luigi Gonzaga" University Hospital, 10043, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2321-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375302PMC
April 2015

Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome.

World J Radiol 2014 Aug;6(8):583-8

Luciano Cardinale, Francesco Asteggiano, Federica Moretti, Federico Torre, Institute of Radiology, Department of Clinical and Biological Sciences, University of Turin, AOU S.Luigi Gonzaga, 10043 Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4329/wjr.v6.i8.583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147438PMC
August 2014

Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11-12, 2013.

Crit Rev Oncol Hematol 2014 Jun 17;90(3):181-9. Epub 2013 Dec 17.

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Orbassano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.12.010DOI Listing
June 2014

Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant.

Clin Lymphoma Myeloma Leuk 2013 Sep;13 Suppl 2:S272-5

Division of Haematology and Internal Medicine, Department of Clinical and Biological Science, University of Turin, Turin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.05.017DOI Listing
September 2013

Chronic myeloid leukemia: state of the art in 2012.

Curr Oncol Rep 2012 Oct;14(5):379-86

Division of Hematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, 10043, Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-012-0253-9DOI Listing
October 2012

A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients.

J Chromatogr Sci 2011 Nov-Dec;49(10):753-7

Clinical Pharmacology, Clinical and Biological Sciences Department, University of Turin, S. Luigi Hospital, Orbassano, TO, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/chrsci/49.10.753DOI Listing
January 2012

Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution.

Cancer Genet Cytogenet 2010 Jun;199(2):139-42

Oncohematology Unit, Department of Clinical and Experimental Medicine, University of Perugia, S. Maria Hospital, Via Tristano di Joannuccio 1, 05100 Terni, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2010.02.008DOI Listing
June 2010

Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.

Neurol Sci 2008 Jun 9;29(3):185-7. Epub 2008 Jul 9.

Centro di Riferimento Regionale Sclerosi Multipla & Neurobiologia Clinica, Aou S Luigi Gonzaga, Regione Gonzole 10, Orbassano TO, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-008-0934-1DOI Listing
June 2008

New therapeutic approaches and prognostic factors in chronic myeloid leukemia.

Leuk Lymphoma 2008 Apr;49(4):625-8

Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190801896210DOI Listing
April 2008

Corticosteroids can reverse severe imatinib-induced hepatotoxicity.

Haematologica 2006 Jun;91(6 Suppl):ECR27

Divisione di Ematologia dell'Università degli Studi di Torino, Molinette Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
June 2006

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia.

Ann N Y Acad Sci 2004 Dec;1028:423-31

Dept. of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Gonzole 10, 10043, Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1322.050DOI Listing
December 2004

Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias.

Haematologica 2002 Oct;87(10):1014-20

Medicina Interna II, Dipartimento di Scienze Cliniche e Biologiche, Osp. S. Luigi Gonzaga, Orbassano, Italy.

View Article

Download full-text PDF

Source
October 2002

From genes to therapy: the case of Philadelphia chromosome-positive leukemias.

Ann N Y Acad Sci 2002 Jun;963:306-12

Department of Clinical and Biological Sciences, University of Turin, Hospital S. Luigi Gonzaga, 10043, Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2002.tb04122.xDOI Listing
June 2002